 |
GlaxoSmithKline settles US drug rows for $3bnGlaxoSmithKline has agreed in principle to settle its most significant disputes with the US government over the way it marketed and developed its drugs, at a cost of $3 billion, which is covered by existing provisions. The settlement, over More… |
Monday 23 December 2024
